ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,352.96
-0.02%
Dow Jones
38,886.17
0.20%
US Dollar vs MXN
17.8447
-0.23%
Brent Oil
80.175
0.37%
Bitcoin
71,362.90
0.85%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Zynerba Pharmaceuticals Inc (ZYNE)

  7. Zynerba Pharmaceuticals Inc (ZYNE) Noticias

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZYNE
FechaHoraFuenteTítuloSímboloCompañía
08/02/202418:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202315:48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202309:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202308:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202308:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202307:56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202307:31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202307:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202307:00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202315:05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202308:00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202307:00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202315:15GlobeNewswire Inc.Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumNASDAQ:ZYNEZynerba Pharmaceuticals Inc
05/09/202315:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202308:05Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202307:23Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
24/08/202316:23Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/08/202315:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202316:29Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202316:20Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202306:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202306:30PR Newswire (US)HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202315:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202315:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202315:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202315:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
21/06/202315:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
20/06/202306:00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/06/202315:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZYNE

Su Consulta Reciente

NYSE
DIS
Walt Disney
NYSE
BAC
Bank of America
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
FX
USDMXN
US Dollar vs MXN
FX
EURUSD
Euro vs US Dollar
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados